tenk.fyi

Aligos Therapeutics, Inc.

ALGSNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$2.2M

39.5% YoY

Net Income

-$24.2M

81.6% YoY

EPS

$-2.45

88.3% YoY

Cash

$18.3M

50.5% YoY

FY 2025 · As of 2025-12-31